NTLA Shares Calculator
Enter either the number of shares you'd like to purchase OR the total investment you'd like to make.
shares x $21.57 = $215.7
NTLA Charts
NTLA Prices
View the NTLA historical prices.
52WL $21.18
The 52 Week Low is $21.18 set on Tue, Dec 27, 2022.
52WH $47.48
The 52 Week High is $47.48 set on Tue, Feb 1, 2022. The current price, $21.57, is 0% below the 52 Week High.
ATH $179.90
The All-Time High is $179.90 set on Fri, Sep 3, 2021. The current price, $21.57, is 0% below the All Time High.
52 Week Range
NTLA Dividends
NTLA has no dividend history.
0.00%
Annual Dividend Yield
$
Quarterly Dividend Rate
--
Declaration Date
--
Ex-Dividend Date
--
Record Date
--
Payment Date
--
Dividend Frequency
0
Dividend History
NTLA Profile
Intellia Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.
